Figure 3 - Change from baseline in UAS7 in omalizumab refractory cohort (n=7)

Figure 3 - Change from baseline in UAS7 in omalizumab refractory cohort (n=7)

Source: Allakos Inc.

Format

JPEG

Source

Allakos Inc.

Downloads